Cures hiding in plain sight
Our technology unlocks the potential of a proven and safe drug concept and will transform the way drugs are developed, what they cost, and who has access to them.
About Us
Unrivaled speed, safety and effectiveness
Our patented technology allows us to develop biologic drugs extremely quickly, and make them at a cost two to three times lower than traditional methods.
What is everywhere will soon be nowhere
In the short term, we can eradicate several treatable GI infections suffered by hundreds of millions of people around the world. We also see significant near-term opportunities in diseases that can be readily targeted with topical and orally delivered biologics.
C. difficile
$8B
problem for hospitals annually
2.3%
of all US hospital costs annually
Covid-19
50%
of patients endure significant GI symptoms
25%
of patients reported only GI symptoms
Norovirus
25.8M
cruise ship passengers at risk annually
2M
nursing home residents at risk annually
Traveler's diarrhea
50M
travelers at risk annually
29%
affliction rate in US servicemembers
Strategic collaborations expand our reach
Collaboration has helped get us to where we are today, and it is key to addressing the full range of opportunities that exist for low-cost biologics.
In the News
Project includes funding for preliminary engineering work on facility to manufacture over 1 billion doses per year
Experienced Industry Leader to Advance Lumen’s Clinical Pipeline
Lead therapeutic candidates for widespread enteric diseases including C. difficile, norovirus, and traveler’s diarrhea
August 26th, 2020
Genetic Engineering & Biotechnology News